Stockscreener 앱 받기
53.67
0.07%
-0.04
시간 외 거래:
53.67
전일 마감가:
$53.71
열려 있는:
$53.285
하루 거래량:
1.74M
Relative Volume:
0.97
시가총액:
$11.06B
수익:
$2.07B
순이익/손실:
$405.37M
주가수익비율:
27.50
EPS:
1.9513
순현금흐름:
$472.50M
1주 성능:
-3.51%
1개월 성능:
+18.42%
6개월 성능:
+6.13%
1년 성능:
+20.58%
1일 변동 폭
$52.75
$53.78
1주일 범위
$52.61
$56.19
52주 변동 폭
$37.74
$57.81
Qiagen Nv Stock (QGEN) Company Profile
QGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
53.67 | 11.06B | 2.07B | 405.37M | 472.50M | 1.9513 |
|
TMO
Thermo Fisher Scientific Inc
|
578.61 | 222.48B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
218.89 | 155.25B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
670.46 | 54.04B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
230.15 | 40.13B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
133.85 | 37.78B | 6.95B | 1.30B | 1.15B | 4.5696 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-22 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-06-24 | 개시 | Barclays | Overweight |
| 2025-04-04 | 다운그레이드 | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-10-17 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-06-27 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-12-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-12 | 개시 | Robert W. Baird | Outperform |
| 2023-05-23 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-01-18 | 업그레이드 | DZ Bank | Hold → Buy |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-10-14 | 개시 | Redburn | Buy |
| 2021-07-14 | 다운그레이드 | Kepler | Buy → Hold |
| 2021-06-03 | 개시 | Goldman | Neutral |
| 2020-10-06 | 재개 | BofA Securities | Buy |
| 2020-09-28 | 업그레이드 | Kepler | Hold → Buy |
| 2020-08-24 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-08-17 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-08-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-08-14 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-12-26 | 재개 | BofA/Merrill | Underperform |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-11-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-11-14 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2019-11-14 | 업그레이드 | Kepler | Reduce → Hold |
| 2019-10-17 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | 다운그레이드 | Kepler | Hold → Reduce |
| 2019-10-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-10-08 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
모두보기
Qiagen Nv 주식(QGEN)의 최신 뉴스
Earnings Recap: Can Qiagen NV sustain its profitabilityPortfolio Gains Summary & Stepwise Trade Execution Plans - baoquankhu1.vn
Retirement Systems of Alabama Makes New Investment in Qiagen N.V. $QGEN - MarketBeat
Qiagen Stock: Quiet Diagnostics Powerhouse Or Underestimated Growth Story? - AD HOC NEWS
Stock Recap: Is Qiagen NV part of any major index2025 Key Lessons & Verified Stock Trade Ideas - baoquankhu1.vn
94,400 Shares in Qiagen N.V. $QGEN Acquired by Lingohr Asset Management GmbH - MarketBeat
Great Lakes Advisors LLC Purchases New Stake in Qiagen N.V. $QGEN - MarketBeat
Qiagen Reports Goldman Sachs Builds 3.15% Voting Stake via Shares and Derivatives - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
Automated Sample Preparation Research Report 2026 - GlobeNewswire Inc.
QIAGEN Reports Equity Vesting for Departing Supervisory Board Member - The Globe and Mail
Qiagen Takeover Talk Grows As Board Refresh Shapes Next Steps - Sahm
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
Managers' transactions announcement according to article 19 MAR - TradingView
Earnings Preview: Qiagen (QGEN) Q4 Earnings Expected to Decline - Finviz
Are Options Traders Betting on a Big Move in QIAGEN Stock? - Yahoo Finance
Qiagen (QGEN) Expected to Announce Earnings on Wednesday - MarketBeat
Qiagen: Takeover Optionality With A High-Quality Consumables Platform (NYSE:QGEN) - Seeking Alpha
QIAGEN Appoints Mark Stevenson to Supervisory Board - BioSpace
QIAGEN appoints Mark Stevenson to supervisory board By Investing.com - Investing.com Nigeria
QIAGEN appoints Mark Stevenson to supervisory board - Investing.com
Microarrays Market Size to Accumulate Around USD 10.72 Billion by 2033, Driven by Expanding Genomics Research and Advanced Diagnostic Adoption – SNS Insider - GlobeNewswire Inc.
Qiagen (NYSE:QGEN) Seems To Use Debt Rather Sparingly - 富途牛牛
Insider Trends: Does Qiagen NV meet Warren Buffetts criteriaJuly 2025 Short Interest & Smart Money Movement Tracker - baoquankhu1.vn
Buy Signal: Does Qiagen NV meet Warren Buffetts criteriaJuly 2025 Selloffs & Precise Buy Zone Identification - baoquankhu1.vn
Qiagen N.V. (QGEN) Stock Analysis: Navigating the Diagnostics Giant’s Growth Amid Market Challenges - DirectorsTalk Interviews
Zacks Research Has Weak Estimate for Qiagen FY2025 Earnings - MarketBeat
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - Pressetext
Qiagen Reports AFM Notification of DWS Investment’s 2.98% Voting Stake - TipRanks
Goldman Sachs Discloses 2.92% Voting Interest in QIAGEN - TipRanks
DWS Investment Discloses 3.06% Voting Stake in QIAGEN - TipRanks
Analysts consider potential Qiagen deal amid reported strategic review By Investing.com - Investing.com Nigeria
Analysts consider potential Qiagen deal amid reported strategic review - Investing.com
Decliners Report: How does Qiagen NV score in quality rankingsExit Point & Technical Buy Zone Confirmations - baoquankhu1.vn
Zacks Research Analysts Lower Earnings Estimates for Qiagen - MarketBeat
Omics Lab Services: Global Market Review 2021-2025 and Forecast 2026-2031 Featuring Profiles of Agilent Technologies, Q2 Solutions, Flomics Biotech, QIAGEN, Thermo Fisher Scientific and More - Yahoo Finance
Deutsche Bank Downgrades Qiagen NV(QGEN.US) to Hold Rating - 富途牛牛
Qiagen Stock Soars Amid Takeover Buzz — Will This Time Be Different? - Smartkarma
Deutsche Bank Downgrades QIAGEN to Hold From Buy, Adjusts Price Target to $54 From $54.74 - marketscreener.com
Deutsche Bank cuts Qiagen to “hold” as takeover speculation lifts shares - Investing.com
Deutsche Bank Downgrades Qiagen (QGEN) to Hold; Price Target Rai - GuruFocus
Deutsche Bank downgrades Qiagen stock to Hold amid takeover speculation By Investing.com - Investing.com South Africa
Deutsche Bank downgrades Qiagen stock to Hold amid takeover speculation - Investing.com
QIAGEN NV : Deutsche Bank is now Neutral - marketscreener.com
Deutsche Bank Downgrades Qiagen NV (QGEN) to Hold - StreetInsider
Qiagen stock jumps on Bloomberg report of potential takeover interest By Investing.com - Investing.com Nigeria
Qiagen (NYSE:QGEN) Sees Large Volume IncreaseHere's Why - MarketBeat
Nephron Initiates Qiagen NV(QGEN.US) With Hold Rating, Announces Target Price $59 - 富途牛牛
Research Alert: Qiagen Reports Of Potential Takeover Emerge - 富途资讯
Germany's DAX Index Closes Lower; Qiagen Climbs - marketscreener.com
Qiagen (QGEN) Hits 4-Year High as Earnings Loom - Finviz
Qiagen Nv (QGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.19%
0.63%
자본화:
|
볼륨(24시간):